Risk factors
Eloxx Pharmaceuticals (ELOX) risk factors
Item 1A of every Eloxx Pharmaceuticals, Inc. 10-K on file, and what changed from one year to the next. Readings are automated and can be wrong; check the filing for the exact wording.
- FY2025 10-K risk factors79 risks
Eloxx Pharmaceuticals faces severe going concern doubts, with insufficient cash for the next twelve months and an accumulated deficit of $300.6 million. Delinquent public filings, delisting from Nasdaq, and dependence on its lead product candidate, exaluren, heavily threaten operations.
Filed Mar 17, 2026